Ratings for Quest Diagnostics (NYSE:DGX ... and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector ...

Quest Diagnostics (DGX) delivered earnings and revenue surprises of 1.83% and 1.96%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Following the earnings announcement, Quest Diagnostics (NYSE:DGX)' stock price rose by 0.48% in pre-market trading. The stock ...

It does not assume any contribution from ... we're doing on the core clinical business to get ready, we do have segments in Quest Diagnostics that already operate under 21 CFR Part A 20.

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine ...

Q4 2024 Earnings Call Transcript January 30, 2025 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is ...

For the fourth quarter of 2024, the Zacks Consensus Estimate for Quest Diagnostics’ revenues is pegged at $2.57 billion, indicating an increase of 12.4% from the year-ago reported figure.

I've only been at Quest Diagnostics for one year ... But after COVID hit, I was looking to do something new and wanted a job where I could be active. After trying to drive and deliver with ...